Early vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer

scientific article

Early vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4172/2165-7092.1000151
P932PMC publication ID4712931
P698PubMed publication ID26779392
P5875ResearchGate publication ID279955304

P2093author name stringSalma K Jabbour
Elizabeth Poplin
Sairaman Nagarajan
Eli D Scher
Darren Carpizo
Sairam Balasubramanian
Rebecca Moss
Laleh Melstrom
Ajay A Patel
Caitlin Ab Schonewolf
David August
P2860cites workPancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-upQ34301038
Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II StudyQ34334926
One thousand consecutive pancreaticoduodenectomiesQ34541222
The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.Q34570963
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trialQ34602771
Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysisQ34629874
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resectionQ34695255
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 studyQ35085084
Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysisQ38137541
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trialQ38391782
Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trialQ39522460
Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?Q43467232
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trialQ43804989
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trialQ46387542
Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.Q50734059
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.Q50950502
Radiation therapy for pancreatic cancer: eleven year experience at the JCRTQ70081135
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectpancreatic cancerQ212961
chemoradiotherapyQ5090613
P577publication date2015-04-02
P1433published inPancreatic disorders & therapyQ27724306
P1476titleEarly vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer
P478volume5

Reverse relations

cites work (P2860)
Q91858994Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS-Driven Sporadic Pancreatic Cancers
Q93182562Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis

Search more.